Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (61-70 of 314) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Chemoradiotherapy in malignant glioma: standard of care and future directionsRoger Stupp, Monika E Hegi, Mark R Gilbert, et al.
Current Neurology and Neuroscience Reports|May 4, 2005
Optimal role of temozolomide in the treatment of malignant gliomasRoger Stupp, Martin J van den Bent, Monika E Hegi
Oncology (Williston Park, N.Y.)|February 16, 2018
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and PrognosisRimas V Lukas, Roger Stupp, Vinai Gondi, et al.
Bulletin Du Cancer|September 20, 2007
[Role of MGMT and clinical applications in brain tumours]Christophe Paus, Anastasia Murat, Roger Stupp, et al.
Critical Reviews in Oncology/Hematology|May 5, 2007
Anaplastic astrocytoma in adultsRoger Stupp, Michele Reni, Gemma Gatta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Bevacizumab and recurrent malignant gliomas: a European perspectiveWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Oncotarget|January 18, 2021
Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapyAdam M Sonabend, Roger Stupp, Catalina Lee-Chang, et al.
Future Oncology (London, England)|October 6, 2010
Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?Michael Weller, Wolfgang Wick, Monika E Hegi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case reviewFatma Ataman, Philip Poortmans, Roger Stupp, et al.
PET Clinics|May 10, 2016
PET Imaging in Glioma: The Neuro-Oncologist's ExpectationsAndreas F Hottinger, Marc Levivier, Laura Negretti, et al.
Pageof 32

Showing results (61-70 of 314) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Chemoradiotherapy in malignant glioma: standard of care and future directionsRoger Stupp, Monika E Hegi, Mark R Gilbert, et al.
Current Neurology and Neuroscience Reports|May 4, 2005
Optimal role of temozolomide in the treatment of malignant gliomasRoger Stupp, Martin J van den Bent, Monika E Hegi
Oncology (Williston Park, N.Y.)|February 16, 2018
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and PrognosisRimas V Lukas, Roger Stupp, Vinai Gondi, et al.
Bulletin Du Cancer|September 20, 2007
[Role of MGMT and clinical applications in brain tumours]Christophe Paus, Anastasia Murat, Roger Stupp, et al.
Critical Reviews in Oncology/Hematology|May 5, 2007
Anaplastic astrocytoma in adultsRoger Stupp, Michele Reni, Gemma Gatta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Bevacizumab and recurrent malignant gliomas: a European perspectiveWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Oncotarget|January 18, 2021
Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapyAdam M Sonabend, Roger Stupp, Catalina Lee-Chang, et al.
Future Oncology (London, England)|October 6, 2010
Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?Michael Weller, Wolfgang Wick, Monika E Hegi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case reviewFatma Ataman, Philip Poortmans, Roger Stupp, et al.
PET Clinics|May 10, 2016
PET Imaging in Glioma: The Neuro-Oncologist's ExpectationsAndreas F Hottinger, Marc Levivier, Laura Negretti, et al.
Pageof 32